Effect of treatment with pegvisomant on meningioma growth in vivo

European Journal of Endocrinology

Volumn 152, Issue 1, 2005, Pages 161-162

  Drake, W M ^b   Grossman, A B ^b   Hutson, R K ^a  

^a UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE; PEGVISOMANT;

ACROMEGALY; AGED; CANCER GROWTH; CANCER INHIBITION; CASE REPORT; DRUG EFFECT; FEMALE; HUMAN; HYPOPHYSIS TUMOR; IN VIVO STUDY; LETTER; MENINGIOMA; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TUMOR VOLUME;

ACROMEGALY; AGED; FEMALE; HUMAN GROWTH HORMONE; HUMANS; MAGNETIC RESONANCE IMAGING; MENINGIOMA; OCTREOTIDE; PITUITARY NEOPLASMS; RECEPTORS, SOMATOTROPIN;

EID: 13244294108     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.01825     Document Type: Letter

References (6)

1. Van der Lely AJ, Hutson RK, Trainer PJ, Besser GM, Barkan AL, Katznelson L, Klibanski A, Herman-Bonert V, Melmed S, Vance ML, Freda PU, Stewart PM, Friend KE, Clemmons DR, Johannsson G, Stavrou S, Cook DM, Phillips LS, Strasburger CJ, Hackett S, Zib KA, Davis RJ, Scarlett JA & Thorner MO. Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. Lancet 2001 358 1754-1759.
2. Trainer PJ, Drake WM, Katznelson L, Freda PU, Herman-Bonert V, van der Lely AJ, Dimaraki EV, Stewart PM, Friend KE, Vance ML, Besser GM, Scarlett JA, Thorner MO, Parkinson C, Klibanski A, Powell JS, Barkan AL, Sheppard MC, Malsonado M, Rose DR, Clemmons DR, Johannsson G, Bengtsson BA, Stavrou S, Kleinberg DL, Cook DM, Phillips LS, Bidlingmaier M, Strasburger CJ, Hackett S, Zib K, Bennett WF & Davis RJ. Treatment of acromegaly with the growth hormone receptor antagonist pegvisomant. New England Journal of Medicine 2000 342 1171-1177.
3. Machinery's Handbook, edn 26. New York, NY: Industrial Press, Inc, 2000.
4. Kopchick JJ, Parkinson C, Stevens EC & Trainer PJ. Growth hormone receptor antagonists: discovery, development, and use in patients with acromegaly. Endocrine Reviews 2002 5 623-646.
5. Friend KE. Cancer and the potential place for growth hormone receptor antagonist therapy. Growth Hormone and IGF Research 2001 11 (Suppl A) S121-S123.
6. McCutcheon IE, Flyvbjerg A, Hill H, Li J, Bennett WF, Scarlett JA & Friend KE. Antitumor activity of the growth hormone receptor antagonist pegvisomant against human meningiomas in nude mice. Journal of Neurosurgery 2001 94 487-492.